NOTA! Questo sito utilizza i cookie e tecnologie simili.

Se non si modificano le impostazioni del browser, l'utente accetta. Per saperne di piu'

Approvo

12th Meet The Professor

Advanced International Breast Cancer Course (AIBCC)

Padua, September 29th - 30th, October 1st 2016



  • Aims
  • Awards & Fellowships
  • Directors
  • Scientific Committee
  • Speakers & Chairmen
  • Program
  • Registration

Breast cancer represents the front runner in cancer research in many aspects. First, this is a common, chronic and lethal disease where medical interventions are successfully inducing a continuous decline in mortality in spite of increasing incidence. Second, biology drives the entire diagnostic-therapeutic work up of these patients. This is why, nowadays, a breast multidisciplinary team should also include pathologists, molecular biologists, oncogeneticists besides the "classic" clinical specialties. Third, many highly effective interventions are available for each step of the diagnostic and therapeutic work-up of these patients. The increased complexity of the disease, the availability of multiple effective choices and the high expectations of our patients are raising the bar of clinical excellence in this field.
With this goal in mind, the Programme of this international Conference includes lectures on molecular characterization, updated treatments of early and advanced disease, management of difficult cases and hereditary syndromes.
Clinical case discussions and debates are planned to allow a continuous and fruitful exchange of experiences and opinions between speakers and participants.
This 12th Breast Cancer Conference includes a highly qualified international faculty, but will maintain its characteristics of a friendly forum where international opinion leaders and attendees will exchange experiences and share the most exiting advances.
In order to reward scientific excellence and to foster international cooperation, the International Scientific Committee of the 12th AIBCC will award the 6th International Prize for Breast Cancer Research to a scientist who has published a breakthrough paper in the previous year.
We welcome medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists to listen to breast cancer leaders and to exchange experiences in a friendly atmosphere.

Addressed to

Gynaecologists and obstetrics, medical oncologists, pathologists, radiologists, radiation oncologists, surgeons. Biologists and nurses.

Official Language

The official language of the Meeting is English. No simultaneous translation will be provided.

CME

Based on Italian regulations, Accademia Nazionale di Medicina (provider n. 31) will assign to the activity CME (31-162332): 8 CME points.

The Meeting is addressed to physicians specialized in oncology, radiodiagnostics, radiotherapy, clinical pathology, general surgery, gynaecology and obstetrics, biologists and nurses. It will not be possible to give credits to physicians specialized in different fields.

The credit certification is subject to:

  • attendance at the entire Meeting
  • the completion of the Meeting evaluation form
  • the completion of the final questionnaire (at least 75% of correct answers)

We would like to remind you to participants that only 1/3 of CME credits acquired during the years 2014/2016 can come from a sponsorship.

 

UNIVERSITY OF PADUA AWARD FOR ADVANCES IN BREAST CANCER 2016

The Scientific Committee will select young researchers (< 40 years from any country) who have published in an international peer-reviewed journal, as the principal author, a manuscript reporting important clinical or biological advances in breast cancer. Prof. Conte and Prof. Hortobagyi will select the final winner which will be invited to present his/her study during the annual Conference.

Download Application Form

CASE HISTORIES

Participants can send one or more case history to the scientific committee. The selected ones will be discussed during one of the three tumor boards (please see the program).
People sending the selected case histories will have to present them and will have free registration, dinners and accommodation as well as a reimbursement of travel expenses (max of travel reimbursement 200,00 € for Italian participants and €300,00 for European participants).
Case histories should be sent within August 25th.
A confirmation will be sent by email within September 2nd.
For further details please click here.

FELLOWSHIPS

Some fellowship (for under 40) will be awarded which will include registration and 3 Hotel nights. Those interested should send the registration form together with a short CV and a motivation letter within August 25th.
The organizing secretariat will confirm the award of the fellowship within September 2nd and it will proceed with the organization of logistics.

UNDER 35

Free admission is available for 3 people "under 35". Registration forms will be accepted on a first-come, first-served basis until spaces will be full. The Organization Secretariat will confirm the registration by email.

Foto

Pier Franco Conte

Division of Medical Oncology 2

Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology
and Gastroenterology
University of Padua (I)

Foto

Gabriel N. Hortobagyi

Department of Breast Medical Oncology

The University of Texas - MD Anderson Cancer Center
Houston (USA)

Jonas Bergh

Department of Oncology-Pathology
Karolinska Institute and University Hospital
Stockholm (SW)

Hesham Ahmed Gaballah Elghazaly

Department of Clinical Oncology and nuclear medicine
University of Ainshams
Cairo (EG)

Valentina Guarneri

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Jacek Jassem

Department of Oncology and Radiotherapy
Medical University of Gdansk (PL)

Stephen Johnston

NIHR Biomedical Research Centre for Cancer
Royal Marsden NHS Foundation Trust & Institute of Cancer Research
London (UK)

Sibylle Loibl

German Breast Group
Department of Medicine and Research
University of Frankfurt (D)

Miguel Martin

Medical Oncology Service
Hospital Universitario Gregorio Marañon
Madrid (S)

Stefano Merigliano

Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Donato Nitti

Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Philip Poortmans

President-elect of ESTRO
Department of Radiation Oncology
Radbound University Medical Centre
Nijmegen (NL)

Camillo Aliberti

Unit of Oncological Interventional Radiology
Istituto Oncologico Veneto
Padua (I)

Alberto Amadori

Division of Oncological Molecular Diagnostic and Immunology
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Livia S.A. Augustin

Department of Nutritional Sciences
University of Toronto
Toronto

Jonas Bergh

Department of Oncology-Pathology
Karolinska Institute and University Hospital
Stockholm (SW)

Fernando Bozza

Division of Breast Surgery
Istituto Oncologico Veneto IRCCS
Padua (I)

Robert E. Coleman

Academic Unit of Clinical Oncology
Weston Park Hospital - University of Sheffield
Sheffield (UK)

Ettore Capoluongo

Department of Clinical Molecular Diagnostics
University Hospital "Gemelli"
Rome (I)

Pier Franco Conte

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Maia Dzhugashvili

Department of Radiation Oncology
Instituto Madrileño de Oncología (Grupo IMO)
Murcia (E)

Julia Lynn Fishwick

Salute Donna
Milan (I)

Hesham Ahmed Gaballah Elghazaly

Department of Clinical Oncology and Nuclear Medicine
University of Ainshams (E)

Roberto Gennari

Department of Surgery
AUSL Romagna
Ravenna (I)

Stefania Gori

Dipartimento di Oncologia Medica,
Hospital Sacro Cuore Don Calabria
Negrar (I)

Alessandra Graziottin

Center of Gynaecology and Sessuology
Hospital San Raffaele Resnati
Milano (I)

Valentina Guarneri

Division of Medical Oncology 2
Istituto Oncologico Veneto IRCCS
Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Nadia Harbeck

Department Management, Breast Center and Oncological day clinic
Frauenklinik der Universität
München (D)

Gabriel N.Hortobagyi

Department of Breast Medical Oncology
The University of Texas - MD Anderson Cancer Center
Houston (USA)

Jacek Jassem

Department of Oncology and Radiotherapy
Medical University of Gdansk (PL)

Stephen Johnston

NIHR Biomedical Research Centre for Cancer
Royal Marsden NHS Foundation Trust & Institute of Cancer Research
London (UK)

Sibylle Loibl

German Breast Group
Department of Medicine and Research
University of Frankfurt (D)

Michele Maio

Department of Cancer Immunotherapy
A.O.U.
Siena (I)

Miguel Martin

Medical Oncology Service
Hospital Universitario Gregorio Marañon
Madrid (S)

Stefano Merigliano

Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Stefania Migliuolo

Europa Donna Italia
Milan (I)

Marco Montagna

Hereditary Tumors Group Breast and Ovary Cancer
Department of Oncological Molecular Diagnostic and Immunology
Istituto Oncologico Veneto

Monica Morrow

Breast Service, Department of Surgery
Memorial Sloan-Kettering Cancer Center
New York

Donato Nitti

Department of Surgery, Oncology and Gastroenterology
University of Padua (I)

Enrico Orvieto

General Pathology and Cythopatology Unit
Department of Medicine-DIMED
University of Padua (I)

Fedro Alessandro Peccatori

Department of Medical Oncology
European Institute of Oncology (IEO)
Milan (I)

Luigi Pescarini

Department of Radiology
Diagnostic Breast Unit
Istituto Oncologico Veneto IRCCS
University of Padua (I)

Claudio Pilerci

Area Social Health
Regione Veneto
Venezia (I)

Philip Poortmans

President-elect of ESTRO
Department of Radiation Oncology
Radbound university medical centre
Nijmegen (NL)

Aleix Prat

Institute of Oncology (VHIO)
Vall d'Hebron- Institute of Oncology
Barcellona (E)

Pietro Ruggieri

Department of Orthopaedics and Orthopaedic Oncology
University of Padua (I)

Peter Schmid

Centre for Experimental Cancer Medicine
Bart Cancer Institute
Queen Mary University
London (UK)

Neda Stjepanovic

High Risk and Cancer Prevention Group
Val D'Hebron University Hospital
Barcellona (E)

Sandra M. Swain

Medical Director
Washington Cancer Institute
Washington (USA)

Corrado Tinterri

Department of Senology
Istituto Clinico Humanitas
Rozzano (MI)

Manuel Zorzi

Veneto Cancer Registry
Veneto Region
Padua (I)

Preliminary Program

Thursday, September 29th

9.00

Registration

9.45

Introduction to the Course
Pier Franco Conte, Gabriel N. Hortobagyi

SESSION I - LIFE BEFORE AND AFTER BREAST CANCER

Chairmen: Gabriel N. Hortobagyi, Manuel Zorzi

10.00

Diet before and after breast cancer
Livia S.A. Augustin

10.30

Fertility after breast cancer diagnosis
Fedro Peccatori

11.00

Breast cancer and sexuality
Alessandra Graziottin

11.30

Coffee break

SESSION II - BREAST CANCER IN ITALY

Chairmen: Pier Franco Conte, Stefania Gori

12.00

Breast cancer incidence and mortality over time in Italy
Manuel Zorzi

12.30

The Breast Unit: state of art
Claudio Pilerci

12.50

Indices of appropriateness and efficacy: the Periplo Project
Pier Franco Conte

13.10

Lunch

SESSION III - HIGH RISK WOMEN

Chairmen: Alberto Amadori, Sibylle Loibl

14.00

Identification of high risk women: from family history to multigene assays
Ettore Capoluongo

14.30

Risk reduction strategy and management of mutations carriers
Neda Stjepanovic

15.00

Multidisciplinary Tumor Board 1 – Management of high risk women
Chairmen: Gabriel H. Hortobagyi, Luigi Pescarini
Fellows will present case histories, will ask questions to the audience and the participants will vote their preferred choices. A panel of experts including oncogenetists, radiologists, surgeons, oncologists and representatives of advocacy group will comment the votes and express their opinions.
Participants: Maia Dzhugashvili, Julia Lynn Fishwick, Valentina Guarneri, Sibylle Loibl, Stefania Migliuolo, Marco Montagna, Monica Morrow, Philip Poortmans, Corrado Tinterri.

16.30

Coffee break

SESSION IV - SURGERY

Chairmen: Fernando Bozza, Pier Franco Conte

17.00

In situ carcinomas: state of art
Monica Morrow

17.20

Positive sentinel node: when axillary dissection can be spared
Corrado Tinterri

17.40

Lipofilling and breast reconstruction: all good or some risks?
Roberto Gennari

18.00

Discussion

18.30

Adjourn

Friday, September 30th

SESSION V - BREAST CANCER SUBTYPES: ACTIONABLE PROGNOSTIC AND PREDICTIVE PATHWAYS

Chairmen: Pier Franco Conte, Philip Poortmans

9.00

Triple negative breast cancer
Aleix Prat

9.30

HER2+ breast cancers
Sibylle Loibl

10.00

HR+ breast cancers
Stephen Johnston

10.30

Multiple assays to predict risk of early and late recurrence and benefit of treatment in HR+ disease
Gabriel N. Hortobagyi

10.30

Coffee break

11.30

Multidisciplinary Tumor Board 2 – Biological characterization and adjuvant algorithms
Chairmen: Gabriel N. Hortobagyi, Philip Poortmans
Fellows will present case histories, will ask questions to the audience and the participants will vote their preferred choices. A panel of experts including oncologists, pathologists, radiation oncologists, surgeons and representatives of advocacy group will comment the votes and express their opinions.
Participants: Pier Franco Conte, Julia Lynn Fishwick, Jassem Jassek, Stephen Johnston, Sibylle Loibl, Stefania Migliuolo, Sandra Swain, Enrico Orvieto, Aleix Prat, Corrado Tinterri.

13.00

Lunch

SESSION VI – ADJUVANT TREATMENTS OF EARLY BREAST CANCER

Chairman: Sibylle Loibl, Stephen Johnston

14.00

Triple negative disease
Miguel Martin

14.30

HER2+ disease
Valentina Guarneri

15.00

HR+ disease
Jonas Bergh

15.30

Anti-resorptive agents: role in the adjuvant setting
Robert Coleman

16.00

Radiation therapy: local and systemic efficacy
Philip Poortmans

16.30

Immune checkpoint inhibitors: premises and promises
Peter Schmid

17.00

Q&A

17.15

Adjourn

17.45

Ceremony for the presentation of the University of Padua Award for Advances in Breast Cancer 2016

18.00

Lecture of the Awardee

18.30

Cocktail

20.00

Adjourn

The Ceremony and the cocktail will take place in MUSME (Museo di Storia della Medicina , Via Francesco 94, Padova)

Saturday, October 1st

9.00

Multidisciplinary Tumor Board 3 – Management of advanced breast cancer
Chairmen: Pier Franco Conte, Stefano Merigliano
Fellows will present case histories, will ask questions to the audience and the participants will vote their preferred choices. A panel of experts including oncologists, pathologists, radiologists, radiation oncologists, surgeons and representatives of advocacy group will comment the votes and express their opinions.
Participants: Camillo Aliberti, Jonas Bergh, Julia Lynn Fishwick, Hesham Ahmed Gaballah Elghazaly, Gabriel N. Hortobagyi, Nadia Harbeck, Miguel Martin, Stefania Migliuolo, Donato Nitti, Enrico Orvieto, Philip Poortmans, Aleix Prat, Pietro Ruggieri, Sandra Swain.

11.00

Coffee break

SESSION VII - NEW DRUGS, NEW HOPES

Chairman: Jonas Bergh

11.30

Targeted agents for HR+ disease
Nadia Harbeck

12.00

New antiHER2 agents
Sandra Swain

12.30

Immune check point inhibitors: what we learnt from other tumors
Michele Maio

12.50

Q&A

13.00

Adjourn and final evaluation questionnaire

Registration Fee

€ 250.00

€150.00 for graduate students

€ 150.00 for nurses

Tax free.

It includes the conference bag, the conference book and all coffee breaks and lunches. It does not include Hotel accomodation, dinners and travel expenses.


Under 35

Free admission is available for 3 persons “under 35”. Registration forms will be accepted on a first-come, first-served basis unitil spaces are filled. The Organization Secretariat will confirm the registration by email.

Click on the following button to open the on line registration form (in italian language):

Enroll

…or click on the following button for the application form in english (PDF document): download it, print it, fill it out manually and send it via fax to number +39.051.0569.162 (instructions inside):

Download registration form (PDF)

Meeting Venue

Centro Congressi Padova A. Luciani, Via Forcellini 170/A, Padova.
+39.049.803.37.11

Stampa

 

How to reach the meeting venue